8-K current report · filed Aug 5, 2026

Schrodinger, Inc. (SDGR) 8-K Current Report: August 5, 2026

Item 2.02Item EX-99.1SDGR overview

Short answer

Schrodinger, Inc. (SDGR) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 FY2026 results released August 5, 2026, covering quarter ended June 30, 2026.

Schrodinger, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q2 FY2026 results released August 5, 2026, covering quarter ended June 30, 2026
  • Full financial results furnished in Exhibit 99.1, requiring review for revenue, profitability, and guidance
  • Disclosure not deemed “filed” under Exchange Act Section 18, limiting associated liability protections

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $58.9M, up 8%, led by drug discovery revenue $23.0M versus $13.9M
  • ACV $29.6M, up 27%, while software revenue fell 10% to $32.5M amid the hosted-licensing transition
  • Net income $6.0M versus $43.2M loss, driven largely by $45.9M fair-value gains on equity investments
  • Cash, restricted cash and marketable securities $418.8M, but operating cash flow was negative $48.9M in the first half
  • 2026 ACV outlook $218M-$228M, with drug discovery revenue guidance raised to $65M-$75M after the $10M Ajax milestone

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Schrodinger, Inc. 8-K filings

Get the next SDGR 8-K as it lands

Follow SDGR for push alerts, or ask the research agent what this filing means.